Genomic Expression Inc

RNA platform for Next Generation Cures. By analyzing RNA we can detect disease, monitor health and design cures

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Boston, MA, US
  • Currency USD
  • Founded July 2017
  • Employees 15
  • Incorporation Type C-corp
  • Website genomicexpression.com

Company Summary

Commercial Stage RNA Platform For Next Generation Cures in Cancer with an exponentially scalable platform that is disease agnostic.

By analyzing RNA we can detect disease, monitor health, and design next-generation cures.

The OneRNA® Platform enables the rapid design and test of RNA Therapeutics and repurposing of existing drugs on an individual patient basis.

The OneRNA Platform is CLIA-validated in breast cancer and soon also in Ovarian cancer

Team

  • Morten Lorentz Pedersen
    CTO, PhD

    Inventor of the GEx's technologies
    PhD in Genetics at the JFK Institute
    Strong innovation track record

  • Gitte Pedersen
    CEO

    20+ years of management experience
    Deal resume north of $1 billion
    Master’s in Chemical Engineering

  • Jesper Zeuthen
    CMO, PhD

    Co-founder of GenMab & Topotarget
    Raised more than $650 for Bankinvest
    Karolinska, The Danish Cancer Society

  • Gitte Pedersen
    Lab Director, MD PHD | Medical Director

    Foundation Medicine, Quest, Invitae, Illumina

Advisors

  • Duane Morris LLP
    Lawyer
    Unconfirmed
    FullSky Partners
    Unconfirmed
    FullSky Partners
    Unconfirmed
  • Berdon, CPA
    Unconfirmed

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free